All Access Articles |
- Key Focus for BridgeBio Pharma Investors | 2025-08-29 | PHARMACEUTICAL
- Unveiling BridgeBio Pharma – A Fundamental Analysis | 2025-08-18 | PHARMACEUTICAL
- Brief Report on BridgeBio Pharma Stock | 2025-08-12 | PHARMACEUTICAL
- Navigating BBIO - Key Insights for Investors | 2025-06-30 | PHARMACEUTICAL
- Unlocking Key Insights into BridgeBio Pharma | 2025-05-14 | PHARMACEUTICAL
- BridgeBio Pharma 10-Q Report Reveals Diverse Pipeline and FDA Approvals | 2025-04-30 | PHARMACEUTICAL
- BridgeBio Pharma Reports Positive Results in Phase 2 Trial of Infigratinib for Achondroplasia | 2024-06-06 | PHARMACEUTICAL